Cytek Biosciences Inc
F:8EQ

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
F:8EQ
Watchlist
Price: 4.58 EUR 2.69% Market Closed
Market Cap: €601.2m

Wall St Price Targets

8EQ Price Forecast
Based on 7 analysts

-16% Downside
from €4.58 today

8EQ Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 8EQ yet.

Cytek Biosciences Inc Competitors:
Price Targets

Revenue
Forecast

17% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
17% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 7%.

Gross Profit
Forecast

15% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
15% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 5 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 8%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 8EQ's stock price target?
Price Target
3.85 EUR

According to Wall Street analysts, the average 1-year price target for 8EQ is 3.85 EUR with a low forecast of 3.62 EUR and a high forecast of 5.94 EUR.

What is the Revenue forecast for Cytek Biosciences Inc?
Projected CAGR
7%

Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 7%.

What is the Gross Profit forecast for Cytek Biosciences Inc?
Projected CAGR
8%

Over the last 5 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 8%.

Back to Top